MGI Tech Co., Ltd. (SHSE: 688114)
Health Care · Life Sciences Tools & Services · CN
CN¥71.90
-4.06% today · +0.8% 1Y
MGI Tech Co., Ltd. (SHSE: 688114) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $4.42B.
Over the last twelve months the share price has gained 0.8%, trading between 44.88 and 82.88.
Tweenvest scores MGI Tech Co., Ltd. across four factors: quality 65/100, value 39/100, growth 0/100. Its strongest factor is quality.
688114 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.42B
- Revenue (TTM)
- $441.18M
- P/E
- —
- EPS
- -0.51
- Dividend yield
- —
- Beta (5Y)
- 0.29
- 52-week high
- CN¥82.88
- 52-week low
- CN¥44.88
- Avg volume (3M)
- —
- Shares outstanding
- 411.90M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Stevanato Group S.p.A.NYSE: STVN | $5.31B | $19.22 | -1.13% |
| Sotera Health CompanyNasdaqGS: SHC | $5.20B | $17.83 | -2.14% |
| Joinn Laboratories(China)Co.,Ltd.SHSE: 603127 | $5.03B | CN¥49.30 | +6.27% |
| Anthem Biosciences LimitedNSEI: ANTHEM | $5.01B | Rs855.75 | -2.04% |
| XtalPi Holdings LimitedSEHK: 2228 | $4.36B | HK$7.95 | +2.52% |
| SCHOTT Pharma AG & Co. KGaAXTRA: 1SXP | $4.24B | €24.65 | -1.99% |
| Adaptive Biotechnologies CorporationNasdaqGS: ADPT | $4.19B | $26.08 | -0.76% |
| AbCellera Biologics Inc.NasdaqGS: ABCL | $4.16B | $12.10 | -5.69% |
Figures last refreshed Oct 4, 2026.